Moneycontrol PRO
HomeNewsBusinessStocksDr Reddys Labs shares fall 1.21% on Monday, among top losers on Nifty 50

Dr Reddys Labs shares fall 1.21% on Monday, among top losers on Nifty 50

With its stock last trading at Rs 1,300.80, Dr Reddys Labs experienced a decline in yesterday's trade and was among the top losers on the Nifty 50 index.

September 16, 2025 / 08:13 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Shares of Dr Reddys Labs fell on Monday, declining by 1.21% to Rs 1,300.80, compared to its previous close. The stock was among the top losers on the Nifty 50 in yesterday's trading. Dr Reddys Labs is a constituent of the Nifty 50 index.

Trading Volume and Market Impact

Trading activity for Dr Reddys Labs suggested a marginal decrease in volume during this period. However, detailed volume analysis requires specific exchange data, which is not available.

Performance vs. Benchmark Indices

Detailed performance data against benchmark indices like Nifty Midcap 150 and specific timeframes (1Y, 6M, 1M) are not available. Therefore, a comparative analysis cannot be accurately provided.

Company and Market Positioning

Data regarding the market capitalization, ownership breakdown (promoter, institutional, retail), and sector positioning of Dr Reddys Labs are not available. Therefore, a comprehensive analysis of the company's market positioning cannot be provided.

Recent Corporate Actions and Financial Performance

Recent data regarding corporate actions such as dividends, bonus issues, and stock splits is not available. However, the following tables provide insights into the company's financial performance based on available data.

Financial Data

(Note: The following tables are based on the available financial data. Please note that some data points may be missing.)

Income Statement (Yearly - Standalone)

Unfortunately, comprehensive financial data, including income statements, balance sheets, and cash flow statements, is unavailable. The provided data indicates that the lists for both quarterly and yearly income statements are empty. Consequently, a detailed financial analysis cannot be performed at this time.

Corporate Actions

Based on the available data, no recent corporate actions such as bonus issues, stock splits, or rights issues have been announced. The dividend data shows no specific dividend announcements.

Market Outlook and Investor Sentiment

According to Moneycontrol analysis, the market sentiment for Dr Reddys Labs is neutral.

With its stock last trading at Rs 1,300.80, Dr Reddys Labs experienced a decline in yesterday's trade and was among the top losers on the Nifty 50 index.

Alpha Desk
first published: Sep 16, 2025 08:13 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347